Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02978027 · ClinicalTrials.gov registry record · NA

Mentored Research on Improving Alcohol Brief Interventions in Medical Settings

A NA study, sponsored by University of New Mexico.

Completed
Registry status
NA
Development phase
93
Enrollment target

NCT02978027: Completed NA study, sponsored by University of New Mexico.

NCT02978027 is a NA study that has completed, run by University of New Mexico. The registered enrollment target is 93 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02978027, a NA study, has completed, sponsored by University of New Mexico.

COMPLETED
Registry status
NA
Development phase
93 participants
Enrollment target

Study Summary

The NIAAA estimates that 16% (40 million) of adults in the US are drinking at unsafe levels. More than 50% of alcohol health consequences occur in risky, non-dependent drinkers. Increasing the efficacy and efficiency of brief interventions in medical setting could significantly reduce the public health impacts of risky drinking. There is intense interest in conducting motivational interviewing (MI) informed brief interventions for risky alcohol use in medical settings, but little empirical information is available regarding which MI behavioral and interpersonal style components drive effectiveness. The field would benefit greatly from empirically-based Stage 1 treatment development and modeling studies to delineate the degree to which adding motivational interviewing components to brief intervention improves outcome.

Interventions

  • BEHAVIORAL Motivational Interviewing (MI)
  • BEHAVIORAL Brief Advice
  • BEHAVIORAL NIAAA Clinician's Guide

Trial Details

FieldValue
Enrollment Target 93 participants
Start Date 2014-07
Est. Completion 2017-09
Phase NA
University of New Mexico

168 total trials

What the finished NCT02978027 record still lists

NCT02978027 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 93 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).

The record links to 0 conditions, and to 3 interventions - of which Motivational Interviewing (MI) is the first listed.

NCT02978027 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02978027 about?

NCT02978027 is a clinical study titled "Mentored Research on Improving Alcohol Brief Interventions in Medical Settings". The NIAAA estimates that 16% (40 million) of adults in the US are drinking at unsafe levels. More than 50% of alcohol health consequences occur in risky, non-dependent drinkers. Increasing the efficacy and efficiency of brief interventions in medical setting could significantly reduce the public hea...

What is the current status of trial NCT02978027?

This trial is currently completed. It is a NA study. The enrollment target is 93 participants. The study started on 2014-07. Estimated completion is 2017-09.

What interventions are being tested in trial NCT02978027?

The interventions under investigation include: Motivational Interviewing (MI) (BEHAVIORAL), Brief Advice (BEHAVIORAL), NIAAA Clinician's Guide (BEHAVIORAL).

Who is sponsoring clinical trial NCT02978027?

This trial is sponsored by University of New Mexico, which has 168 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02978027's enrollment target sits among peer trials

93 937th of 2000 higher than 1,064 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02203526 · 93 participants · Phase 1

    Phase 1 Study of Ibrutinib and Immuno-Chemotherapy Using Temozolomide, Etoposide, Doxil, Dexamethasone, Ibrutinib,Rituximab (TEDDI-R) in Primary CNS Lymphoma

  • NCT03089554 · 93 participants · Phase 2

    Evaluating Genomic Testing in Human Cancer & Outcomes of Targeted Therapies

  • NCT05000021 · 93 participants · NA

    Reducing Diabetes Distress Using Cognitive Behavioral Therapy in Young Adults With Type 1 Diabetes

  • NCT05489887 · 93 participants · Phase 2

    Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02978027, the US trial registry maintained by the National Library of Medicine. NCT02978027 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.